Methadone in primary care in France: Using evidence for action against hepatitis C

P. Roux (1) , A. Morel (2) , D. Wolfe (3) , Patrizia M. Carrieri (1)

1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
2 Association de prévention et de soin en addictologie - Oppelia [Paris]
3 OSI - Open Society Foundations

In France, two opioid substitution treatments have been available since the mid-1990s: buprenorphine through primary care and specialized clinics, and methadone only through specialized clinics.

Keywords: Methadone; Hepatitis C; Primary care; Advocacy; Scientific evidence

Domains: Life Sciences [q-bio]; Santé publique et épidémiologie

P. Roux, A. Morel, D. Wolfe, Patrizia M. Carrieri. Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy, 2019, 71, pp.91-92. ⟨10.1016/j.drugpo.2019.06.013⟩. ⟨hal-02613452⟩